New insights into the role of erythrocytes in thrombus formation

Seminars in Thrombosis and Hemostasis

Volumn 40, Issue 1, 2014, Pages 72-80

  Du, Vivian X ^a,b   Huskens, Dana ^c,d   Maas, Coen ^a   Al Dieri, Raed ^c,d   De Groot, Philip G ^a   De Laat, Bas ^a,b,c,d  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b SANQUIN RESEARCH   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d Synapse BV   (Netherlands)

Author keywords

coagulation; erythrocyte; hemostasis; thrombin; thrombosis

Indexed keywords

BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 12; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; BLOOD CLOTTING FACTOR 9A; ERYTHROCYTE BAND 3 PROTEIN; ERYTHROCYTE MEMBRANE PROTEIN 1; GLYCOPROTEIN; HEMOGLOBIN; HIGH MOLECULAR WEIGHT KININOGEN; INTRACELLULAR ADHESION MOLECULE 4; MEIZOTHROMBIN; PHOSPHATIDYLSERINE; PREKALLIKREIN; PROCOAGULANT; PROTHROMBIN; THROMBIN; THROMBOPLASTIN; UNCLASSIFIED DRUG;

ARTICLE; BLEEDING; BLOOD CLOTTING; BLOOD FLOW; BLOOD RHEOLOGY; BLOOD VESSEL WALL; BLOOD VISCOSITY; CHRONIC KIDNEY FAILURE; DIABETES MELLITUS; ENDOTHELIUM CELL; ERYTHROCYTE; ERYTHROCYTE AGGREGATION; ERYTHROCYTE DEFORMABILITY; ERYTHROCYTE FUNCTION AND CHARACTERISTICS; ERYTHROCYTE MEMBRANE; FEEDBACK SYSTEM; FIBRIN FORMATION; HEMATOCRIT; HUMAN; NONHUMAN; OBESITY; OXIDATIVE STRESS; PHENOTYPE; PHOSPHOLIPID VESICLE; PRIORITY JOURNAL; PROTEIN INTERACTION; SEPSIS; SHEAR RATE; SHEAR STRESS; SICKLE CELL ANEMIA; STOMATOCYTOSIS; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE COUNT; THROMBOCYTE POOR PLASMA; THROMBOSIS; THROMBUS;

BLOOD COAGULATION; BLOOD PLATELETS; ERYTHROCYTE MEMBRANE; HUMANS; PHOSPHATIDYLSERINES; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; RHEOLOGY;

EID: 84893072067     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0033-1363470     Document Type: Article

References (106)

1. Ruggeri Z. M. Von Willebrand factor, platelets and endothelial cell interactions. J Thromb Haemost: 2003; 1 7 1335 1342
2. Schafer A. I. Bleeding and thrombosis in the myeloproliferative disorders. Blood: 1984; 64 1 1 12 (Pubitemid 14085720)
3. Randi M. L., Stocco F., Rossi C., Tison T., Girolami A. Thrombosis and hemorrhage in thrombocytosis: evaluation of a large cohort of patients (357 cases). J Med: 1991; 22 4-5 213 223
4. Stewart G. W., Amess J. A., Eber S. W., et al. Thrombo-embolic disease after splenectomy for hereditary stomatocytosis. Br J Haematol: 1996; 93 2 303 310 (Pubitemid 26148734)
5. Michaeli J., Mittelman M., Grisaru D., Rachmilewitz E. A. Thromboembolic complications in beta thalassemia major. Acta Haematol: 1992; 87 1-2 71 74
6. Wong V., Yu Y. L., Liang R. H., Tso W. K., Li A. M., Chan T. K. Cerebral thrombosis in beta-thalassemia/hemoglobin E disease. Stroke: 1990; 21 5 812 816
7. Koshy M., Thomas C., Goodwin J. Vascular lesions in the central nervous system in sickle cell disease (neuropathology). J Assoc Acad Minor Phys: 1990; 1 3 71 78
8. Rossi C., Randi M. L., Zerbinati P., Rinaldi V., Girolami A. Acute coronary disease in essential thrombocythemia and polycythemia vera. J Intern Med: 1998; 244 1 49 53 (Pubitemid 28322605)
9. Zimmermann J., Schramm L., Wanner C., et al. Hemorheology, plasma protein composition and von Willebrand factor in type I diabetic nephropathy. Clin Nephrol: 1996; 46 4 230 236 (Pubitemid 26385557)
10. Kwaan H. C., Levin M., Sakurai S., et al. Digital ischemia and gangrene due to red blood cell aggregation induced by acquired dysfibrinogenemia. J Vasc Surg: 1997; 26 6 1061 1068 (Pubitemid 28018954)
11. Andrews D. A., Low P. S. Role of red blood cells in thrombosis. Curr Opin Hematol: 1999; 6 2 76 82 (Pubitemid 29342520)
12. Gao C., Xie R., Yu C., et al. Procoagulant activity of erythrocytes and platelets through phosphatidylserine exposure and microparticles release in patients with nephrotic syndrome. Thromb Haemost: 2012; 107 4 681 689
13. Tokarev A. A., Butylin A. A., Ataullakhanov F. I. Platelet adhesion from shear blood flow is controlled by near-wall rebounding collisions with erythrocytes. Biophys J: 2011; 100 4 799 808
14. Schreijer A. J., Reitsma P. H., Cannegieter S. C. High hematocrit as a risk factor for venous thrombosis. Cause or innocent bystander? Haematologica: 2010; 95 2 182 184
15. Tannheimer M., Fusch C., Böning D., Thomas A., Engelhardt M., Schmidt R. Changes of hematocrit and hemoglobin concentration in the cold Himalayan environment in dependence on total body fluid. Sleep Breath: 2010; 14 3 193 199
16. Schmid-Schönbein H., Wells R., Goldstone J. Influence of deformability of human red cells upon blood viscosity. Circ Res: 1969; 25 2 131 143
17. Vayá A., Suescun M. Hemorheological parameters as independent predictors of venous thromboembolism. Clin Hemorheol Microcirc: 2013; 53 1-2 131 141
18. Meiselman H. J. Red blood cell aggregation: 45 years being curious. Biorheology: 2009; 46 1 1 19
19. Baskurt O. K., Meiselman H. J. Erythrocyte aggregation: basic aspects and clinical importance. Clin Hemorheol Microcirc: 2013; 53 1-2 23 37
20. Baskurt O. K., Meiselman H. J. Iatrogenic hyperviscosity and thrombosis. Semin Thromb Hemost: 2012; 38 8 854 864
21. Baskurt O. K., Neu B., Meiselman H. J. Red Blood Cell Aggregation. Boca Raton CRC Press: 2011; 1 304
22. Knox R. J., Nordt F. J., Seaman G. V., Brooks D. E. Rheology of erythrocyte suspensions: dextran-mediated aggregation of deformable and nondeformable erythrocytes. Biorheology: 1977; 14 2-3 75 84 (Pubitemid 8155355)
23. Brooks D. E., Goodwin J. W., Seaman G. V. Interactions among erythrocytes under shear. J Appl Physiol: 1970; 28 2 172 177
24. Chien S., Sung L. A., Kim S., Burke A. M., Usami S. Determination of aggregation force in rouleaux by fluid mechanical technique. Microvasc Res: 1977; 13 3 327 333 (Pubitemid 8135794)
25. Chien S., Feng S. S., Vayo M., Sung L. A., Usami S., Skalak R. The dynamics of shear disaggregation of red blood cells in a flow channel. Biorheology: 1990; 27 2 135 147 (Pubitemid 20292914)
26. Bäumler H., Donath E., Krabi A., Knippel W., Budde A., Kiesewetter H. Electrophoresis of human red blood cells and platelets. Evidence for depletion of dextran. Biorheology: 1996; 33 4-5 333 351 (Pubitemid 26375249)
27. Bäumler H., Neu B., Mitlöhner R., Georgieva R., Meiselman H. J., Kiesewetter H. Electrophoretic and aggregation behavior of bovine, horse and human red blood cells in plasma and in polymer solutions. Biorheology: 2001; 38 1 39 51 (Pubitemid 32472866)
28. Neu B., Meiselman H. J. The role of macromolecules in stabilization and de-stabilization of biofluids. In: Artmann G., Chien S., eds. Bioengineering in cell and tissue research. New York Springer: 2008; 387 408
29. Neu B., Meiselman H. J. Depletion interactions in polymer solutions promote red blood cell adhesion to albumin-coated surfaces. Biochim Biophys Acta: 2006; 1760 12 1772 1779 (Pubitemid 44767718)
30. Neu B., Wenby R., Meiselman H. J. Effects of dextran molecular weight on red blood cell aggregation. Biophys J: 2008; 95 6 3059 3065
31. Meiselman H. J., Neu B., Rampling M. W., Baskurt O. K. RBC aggregation: laboratory data and models. Indian J Exp Biol: 2007; 45 1 9 17
32. Baskurt O. K., Meiselman H. J. Hemodynamic effects of red blood cell aggregation. Indian J Exp Biol: 2007; 45 1 25 31
33. Cokelet G. R., Goldsmith H. L. Decreased hydrodynamic resistance in the two-phase flow of blood through small vertical tubes at low flow rates. Circ Res: 1991; 68 1 1 17
34. Fahraeus R. The influence of the rouleau formation of the erythrocytes on the rheology of the blood. Acta Med Scand: 1958; 161 2 151 165
35. Pries A. R., Ley K., Claassen M., Gaehtgens P. Red cell distribution at microvascular bifurcations. Microvasc Res: 1989; 38 1 81 101 (Pubitemid 19188540)
36. Pries A. R., Secomb T. W., Gaehtgens P. Biophysical aspects of blood flow in the microvasculature. Cardiovasc Res: 1996; 32 4 654 667 (Pubitemid 26332305)
37. Baskurt O. K., Yalcin O., Ozdem S., Armstrong J. K., Meiselman H. J. Modulation of endothelial nitric oxide synthase expression by red blood cell aggregation. Am J Physiol Heart Circ Physiol: 2004; 286 1 H222 H229 (Pubitemid 38049483)
38. Yalcin O., Ulker P., Yavuzer U., Meiselman H. J., Baskurt O. K. Nitric oxide generation by endothelial cells exposed to shear stress in glass tubes perfused with red blood cell suspensions: role of aggregation. Am J Physiol Heart Circ Physiol: 2008; 294 5 H2098 H2105
39. James S. H., Meyers A. M. Microangiopathic hemolytic anemia as a complication of diabetes mellitus. Am J Med Sci: 1998; 315 3 211 215 (Pubitemid 28125612)
40. Hebbel R. P. Beyond hemoglobin polymerization: the red blood cell membrane and sickle disease pathophysiology. Blood: 1991; 77 2 214 237
41. Aarts P. A., Banga J. D., van Houwelingen H. C., Heethaar R. M., Sixma J. J. Increased red blood cell deformability due to isoxsuprine administration decreases platelet adherence in a perfusion chamber: a double-blind cross-over study in patients with intermittent claudication. Blood: 1986; 67 5 1474 1481 (Pubitemid 16080622)
42. Chien S. Red cell deformability and its relevance to blood flow. Annu Rev Physiol: 1987; 49 177 192 (Pubitemid 17053889)
43. Lux S. E. Dissecting the red cell membrane skeleton. Nature: 1979; 281 5731 426 429
44. Mohandas N., Shohet S. B. The role of membrane-associated enzymes in regulation of erythrocyte shape and deformability. Clin Haematol: 1981; 10 1 223 237
45. Mohandas N., Chasis J. A. Red blood cell deformability, membrane material properties and shape: regulation by transmembrane, skeletal and cytosolic proteins and lipids. Semin Hematol: 1993; 30 3 171 192 (Pubitemid 23216313)
46. Friederichs E., Meiselman H. J. Effects of calcium permeabilization on RBC rheologic behavior. Biorheology: 1994; 31 2 207 215 (Pubitemid 24150326)
47. Shiga T., Maeda N., Kon K. Erythrocyte rheology. Crit Rev Oncol Hematol: 1990; 10 1 9 48 (Pubitemid 20132286)
48. Davie E. W., Fujikawa K., Kisiel W. The coagulation cascade: initiation, maintenance, and regulation. Biochemistry: 1991; 30 43 10363 10370
49. Renné T., Schmaier A. H., Nickel K. F., Blombäck M., Maas C. In vivo roles of factor XII. Blood: 2012; 120 22 4296 4303
50. Rosing J., Tans G., Govers-Riemslag J. W., Zwaal R. F., Hemker H. C. The role of phospholipids and factor Va in the prothrombinase complex. J Biol Chem: 1980; 255 1 274 283 (Pubitemid 10146055)
51. Hemker H. C., Esnouf M. P., Hemker P. W., Swart A. C., Macfarlane R. G. Formation of prothrombin converting activity. Nature: 1967; 215 5098 248 251
52. van Dieijen G., Tans G., Rosing J., Hemker H. C. The role of phospholipid and factor VIIIa in the activation of bovine factor X. J Biol Chem: 1981; 256 7 3433 3442 (Pubitemid 11077003)
53. Gailani D., Broze G. J. Jr. Factor XI activation in a revised model of blood coagulation. Science: 1991; 253 5022 909 912 (Pubitemid 21917236)
54. Maas C., Meijers J. C., Marquart J. A., et al. Activated factor V is a cofactor for the activation of factor XI by thrombin in plasma. Proc Natl Acad Sci U S A: 2010; 107 20 9083 9087
55. Bevers E. M., Comfurius P., van Rijn J. L., Hemker H. C., Zwaal R. F. Generation of prothrombin-converting activity and the exposure of phosphatidylserine at the outer surface of platelets. Eur J Biochem: 1982; 122 2 429 436 (Pubitemid 12152078)
56. Zwaal R. F., Bevers E. M., Comfurius P., Rosing J., Tilly R. H., Verhallen P. F. Loss of membrane phospholipid asymmetry during activation of blood platelets and sickled red cells; mechanisms and physiological significance. Mol Cell Biochem: 1989; 91 1-2 23 31 (Pubitemid 20007128)
57. Leventis P. A., Grinstein S. The distribution and function of phosphatidylserine in cellular membranes. Annu Rev Biophys: 2010; 39 407 427
58. Yeung T., Gilbert G. E., Shi J., Silvius J., Kapus A., Grinstein S. Membrane phosphatidylserine regulates surface charge and protein localization. Science: 2008; 319 5860 210 213
59. Woon L. A., Holland J. W., Kable E. P., Roufogalis B. D. Ca2+ sensitivity of phospholipid scrambling in human red cell ghosts. Cell Calcium: 1999; 25 4 313 320 (Pubitemid 29353720)
60. Dekkers D. W., Comfurius P., Bevers E. M., Zwaal R. F. Comparison between Ca2+-induced scrambling of various fluorescently labelled lipid analogues in red blood cells. Biochem J: 2002; 362 Pt 3 741 747 (Pubitemid 34242327)
61. Shi J., Shi Y., Waehrens L. N., Rasmussen J. T., Heegaard C. W., Gilbert G. E. Lactadherin detects early phosphatidylserine exposure on immortalized leukemia cells undergoing programmed cell death. Cytometry A: 2006; 69 12 1193 1201 (Pubitemid 46036176)
62. Morel O., Jesel L., Freyssinet J. M., Toti F. Cellular mechanisms underlying the formation of circulating microparticles. Arterioscler Thromb Vasc Biol: 2011; 31 1 15 26
63. van Beers E. J., Schaap M. C., Berckmans R. J., et al. CURAMA study group. Circulating erythrocyte-derived microparticles are associated with coagulation activation in sickle cell disease. Haematologica: 2009; 94 11 1513 1519
64. Horne M. K. III, Cullinane A. M., Merryman P. K., Hoddeson E. K. The effect of red blood cells on thrombin generation. Br J Haematol: 2006; 133 4 403 408
65. Van Der Meijden P. E., Van Schilfgaarde M., Van Oerle R., Renné T., ten Cate H., Spronk H. M. Platelet- and erythrocyte-derived microparticles trigger thrombin generation via factor XIIa. J Thromb Haemost: 2012; 10 7 1355 1362
66. Setty B. N., Rao A. K., Stuart M. J. Thrombophilia in sickle cell disease: the red cell connection. Blood: 2001; 98 12 3228 3233
67. Bonomini M., Sirolli V., Settefrati N., Dottori S., Di Liberato L., Arduini A. Increased erythrocyte phosphatidylserine exposure in chronic renal failure. J Am Soc Nephrol: 1999; 10 9 1982 1990 (Pubitemid 29402520)
68. Bonomini M., Sirolli V., Gizzi F., Di Stante S., Grilli A., Felaco M. Enhanced adherence of human uremic erythrocytes to vascular endothelium: role of phosphatidylserine exposure. Kidney Int: 2002; 62 4 1358 1363
69. Setty B. N., Betal S. G. Microvascular endothelial cells express a phosphatidylserine receptor: a functionally active receptor for phosphatidylserine-positive erythrocytes. Blood: 2008; 111 2 905 914
70. Solá E., Vayá A., Martínez M., et al. Erythrocyte membrane phosphatidylserine exposure in obesity. Obesity (Silver Spring): 2009; 17 2 318 322
71. Ninivaggi M., Apitz-Castro R., Dargaud Y., de Laat B., Hemker H. C., Lindhout T. Whole-blood thrombin generation monitored with a calibrated automated thrombogram-based assay. Clin Chem: 2012; 58 8 1252 1259
72. Peyrou V., Lormeau J. C., Hérault J. P., Gaich C., Pfliegger A. M., Herbert J. M. Contribution of erythrocytes to thrombin generation in whole blood. Thromb Haemost: 1999; 81 3 400 406 (Pubitemid 29116612)
73. Whelihan M. F., Zachary V., Orfeo T., Mann K. G. Prothrombin activation in blood coagulation: the erythrocyte contribution to thrombin generation. Blood: 2012; 120 18 3837 3845
74. Ruf A., Pick M., Deutsch V., et al. In-vivo platelet activation correlates with red cell anionic phospholipid exposure in patients with beta-thalassaemia major. Br J Haematol: 1997; 98 1 51 56 (Pubitemid 27348794)
75. Wood B. L., Gibson D. F., Tait J. F. Increased erythrocyte phosphatidylserine exposure in sickle cell disease: flow-cytometric measurement and clinical associations. Blood: 1996; 88 5 1873 1880 (Pubitemid 26307087)
76. Whelihan M. F., Mann K. G. The role of the red cell membrane in thrombin generation. Thromb Res: 2013; 131 5 377 382
77. Kawakami S., Kaibara M., Kawamoto Y., Yamanaka K. Rheological approach to the analysis of blood coagulation in endothelial cell-coated tubes: activation of the intrinsic reaction on the erythrocyte surface. Biorheology: 1995; 32 5 521 536
78. Kaibara M., Iwata H., Ujiie H., Himeno R., Kaibara M. Rheological analyses of coagulation of blood from different individuals with special reference to procoagulant activity of erythrocytes. Blood Coagul Fibrinolysis: 2005; 16 5 355 363 (Pubitemid 41008743)
79. Kawakami S., Kaibara M., Kawamoto Y., Yamanaka K. Rheological approach to the analysis of blood coagulation in endothelial cell-coated tubes: activation of the intrinsic reaction on the erythrocyte surface. Biorheology: 1995; 32 5 521 536
80. Wautier J. L., Wautier M. P. Molecular basis of erythrocyte adhesion to endothelial cells in diseases. Clin Hemorheol Microcirc: 2013; 53 1-2 11 21
81. El Nemer W., Gauthier E., Wautier M. P., et al. Role of Lu/BCAM in abnormal adhesion of sickle red blood cells to vascular endothelium. Transfus Clin Biol: 2008; 15 1-2 29 33
82. Hermand P., Gane P., Huet M., et al. Red cell ICAM-4 is a novel ligand for platelet-activated alpha IIbbeta 3 integrin. J Biol Chem: 2003; 278 7 4892 4898 (Pubitemid 36800995)
83. Hermand P., Gane P., Callebaut I., Kieffer N., Cartron J. P., Bailly P. Integrin receptor specificity for human red cell ICAM-4 ligand. Critical residues for alphaIIbeta3 binding. Eur J Biochem: 2004; 271 18 3729 3740
84. Joneckis C. C., Ackley R. L., Orringer E. P., Wayner E. A., Parise L. V. Integrin alpha 4 beta 1 and glycoprotein IV (CD36) are expressed on circulating reticulocytes in sickle cell anemia. Blood: 1993; 82 12 3548 3555 (Pubitemid 24006033)
85. Sugihara K., Sugihara T., Mohandas N., Hebbel R. P. Thrombospondin mediates adherence of CD36+ sickle reticulocytes to endothelial cells. Blood: 1992; 80 10 2634 2642
86. Swerlick R. A., Eckman J. R., Kumar A., Jeitler M., Wick T. M. Alpha 4 beta 1-integrin expression on sickle reticulocytes: vascular cell adhesion molecule-1-dependent binding to endothelium. Blood: 1993; 82 6 1891 1899 (Pubitemid 23278781)
87. van Schravendijk M. R., Handunnetti S. M., Barnwell J. W., Howard R. J. Normal human erythrocytes express CD36, an adhesion molecule of monocytes, platelets, and endothelial cells. Blood: 1992; 80 8 2105 2114
88. Wautier J. L., Wautier M. P. Erythrocytes and platelet adhesion to endothelium are mediated by specialized molecules. Clin Hemorheol Microcirc: 2004; 30 3-4 181 184
89. Zen Q., Cottman M., Truskey G., Fraser R., Telen M. J. Critical factors in basal cell adhesion molecule/lutheran-mediated adhesion to laminin. J Biol Chem: 1999; 274 2 728 734
90. Hughes K. R., Biagini G. A., Craig A. G. Continued cytoadherence of Plasmodium falciparum infected red blood cells after antimalarial treatment. Mol Biochem Parasitol: 2010; 169 2 71 78
91. Miller L. H., Good M. F., Milon G. Malaria pathogenesis. Science: 1994; 264 5167 1878 1883 (Pubitemid 24245626)
92. Grossin N., Wautier M. P., Picot J., Stern D. M., Wautier J. L. Differential effect of plasma or erythrocyte AGE-ligands of RAGE on expression of transcripts for receptor isoforms. Diabetes Metab: 2009; 35 5 410 417
93. Wautier J. L., Zoukourian C., Chappey O., et al. Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy. Soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats. J Clin Invest: 1996; 97 1 238 243
94. Ihanus E., Uotila L. M., Toivanen A., Varis M., Gahmberg C. G. Red-cell ICAM-4 is a ligand for the monocyte/macrophage integrin CD11c/CD18: characterization of the binding sites on ICAM-4. Blood: 2007; 109 2 802 810 (Pubitemid 46105985)
95. Sistonen P. Linkage of the LW blood group locus with the complement C3 and Lutheran blood group loci. Ann Hum Genet: 1984; 48 Pt 3 239 242 (Pubitemid 14004301)
96. Sistonen P., Green C. A., Lomas C. G., Tippett P. Genetic polymorphism of the LW blood group system. Ann Hum Genet: 1983; 47 Pt 4 277 284 (Pubitemid 14236485)
97. Bailly P., Tontti E., Hermand P., Cartron J. P., Gahmberg C. G. The red cell LW blood group protein is an intercellular adhesion molecule which binds to CD11/CD18 leukocyte integrins. Eur J Immunol: 1995; 25 12 3316 3320 (Pubitemid 26004934)
98. Ihanus E., Uotila L. M., Toivanen A., Varis M., Gahmberg C. G. Red-cell ICAM-4 is a ligand for the monocyte/macrophage integrin CD11c/CD18: characterization of the binding sites on ICAM-4. Blood: 2007; 109 2 802 810 (Pubitemid 46105985)
99. Hermand P., Gane P., Huet M., et al. Red cell ICAM-4 is a novel ligand for platelet-activated alpha IIbbeta 3 integrin. J Biol Chem: 2003; 278 7 4892 4898 (Pubitemid 36800995)
100. Toivanen A., Ihanus E., Mattila M., Lutz H. U., Gahmberg C. G. Importance of molecular studies on major blood groups-intercellular adhesion molecule-4, a blood group antigen involved in multiple cellular interactions. Biochim Biophys Acta: 2008; 1780 3 456 466 (Pubitemid 351381247)
101. Zennadi R., Hines P. C., De Castro L. M., Cartron J. P., Parise L. V., Telen M. J. Epinephrine acts through erythroid signaling pathways to activate sickle cell adhesion to endothelium via LW-alphavbeta3 interactions. Blood: 2004; 104 12 3774 3781 (Pubitemid 39564457)
102. Lee G., Lo A., Short S. A., et al. Targeted gene deletion demonstrates that the cell adhesion molecule ICAM-4 is critical for erythroblastic island formation. Blood: 2006; 108 6 2064 2071 (Pubitemid 44395022)
103. Du V. X., de Groot P. G., van Wijk R., Ruggeri Z. M., de Laat B. Binding of erythrocyte ICAM-4 to the platelet activated integrin αIIbβ3 leads to a direct erythrocyte-platelet adhesion under venous flow shear rate. Paper presented at: Annual Meeting of the American Society of Hematology; December 9,. 2012;; Atlanta, GA
104. Valles J., Santos M. T., Aznar J., et al. Erythrocytes metabolically enhance collagen-induced platelet responsiveness via increased thromboxane production, adenosine diphosphate release, and recruitment. Blood: 1991; 78 1 154 162
105. Vallés J., Santos M. T., Aznar J., et al. Platelet-erythrocyte interactions enhance alpha(IIb)beta(3) integrin receptor activation and P-selectin expression during platelet recruitment: down-regulation by aspirin ex vivo. Blood: 2002; 99 11 3978 3984 (Pubitemid 35332037)
106. Santos M. T., Valles J., Marcus A. J., et al. Enhancement of platelet reactivity and modulation of eicosanoid production by intact erythrocytes. A new approach to platelet activation and recruitment. J Clin Invest: 1991; 87 2 571 580